Drugs for Rheumatoid Arthritis Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Global Drugs for Rheumatoid Arthritis Market is expected to grow at CAGR of 6.8% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Drugs for Rheumatoid Arthritis Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

ABBVIE

ABLYNX

ALDER BIOPHARMACEUTICALS

AMGEN

BRISTOL-MYERS SQUIBB

CENTOCOR

DAIICHI SANKYO

ELI LILLY

GALAPAGOS NV

GENENTECH (ROCHE)

GILEAD

GLAXOSMITHKLINE

INCYTE CORP.

JANSSEN BIOTECH

JOHNSON & JOHNSON

MEDIMMUNE

MERCK & CO.

PFIZER

REGENERON

SANOFI

UCB

Scope of the Market

Drug Type Market

Nonsteroidal Anti-inflammatory Drugs (NSAIDS)

Corticosteroids

Disease Modifying Anti-rheumatic Drugs (DMARDs)

Biologic Response Modifiers (Biologics)

Distribution Channel Market

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)

Back to top

Payment Options

Single User : $3,897
Five User: $5,175
Enterprise : $9,135
Datapack : $1,299
Short Report : $1,799